Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
NeuroDyne
company
About
NeuroDyn develops medical technology for the diagnosis and treatment of neurological diseases.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $275.64K
- Industries
- Health Care,Medical Device,Product Design
- Founded date
- Jan 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
NeuroDyn develops neurological devices that alleviate seizure activity in children who suffer from congenital brain disease, adults with seizure activity, and veterans who suffer brain damage, enabling the medical community to ensure relief for those who suffer from debilitating seizure effects.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$275.64K
NeuroDyne has raised a total of
$275.64K
in funding over 2 rounds. Their latest funding was raised on
Feb 9, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 9, 2021 | Grant | $275.64K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
NeuroDyne is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
